Roth Capital Starts Intec Pharma Ltd. (NTEC) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Maxim Group Starts Intec Pharma Ltd. (NTEC) at Buy
September 15, 2015 5:00 PM EDTMaxim Group initiates coverage on Intec Pharma Ltd. (NASDAQ: NTEC) with a Buy rating and a price target of $9.00.
Analyt Jason Kolbert commented, "In August 2015, Intec Pharmaceuticals completed its IPO, raising approximately $30M. This is enough capital for its Phase III single (505B2... More
